文献速递腹部泌尿生殖CT

基于术前增强CT的深度学习影像组学列线图鉴别腹膜后脂肪瘤与高分化脂肪肉瘤

Preoperative Contrast-Enhanced CT-Based Deep Learning Radiomics Model for Distinguishing Retroperitoneal Lipomas and Well‑Differentiated Liposarcomas.
PubMed 文献 · Acad Radiol · 2024-07-14

回顾性多中心研究纳入167例MDM2阳性高分化脂肪肉瘤或MDM2阴性脂肪瘤患者,基于术前增强CT构建深度学习影像组学列线图(DLRN)预测MDM2基因扩增以鉴别两者;DLRN在训练组AUC 0.981、外部验证组AUC 0.861,校准曲线和决策曲线显示良好校准与临床获益。

要点

  • DLRN鉴别腹膜后脂肪瘤与高分化脂肪肉瘤训练组AUC 0.981、外部验证组AUC 0.861。
  • DLRN优于临床-影像组学模型和影像组学特征模型(DeLong检验均P<0.05)。
  • DLRN与深度学习影像组学特征模型性能无显著差异(均P>0.05)。

核心结论

  • 基于术前增强CT的深度学习影像组学列线图在术前预测高分化脂肪肉瘤与腹膜后脂肪瘤方面表现出较强的预测能力,有望成为辅助个体化管理和精准医疗的影像生物标志物。

研究设计与样本

  • 回顾性多中心研究,纳入167例MDM2阳性高分化脂肪肉瘤或MDM2阴性脂肪瘤患者,训练组/外部验证组分别为104例/63例;由两名放射科医师独立测量和分析临床数据及增强CT特征;以MDM2基因扩增为参考标准区分高分化脂肪肉瘤与脂肪瘤;构建临床-影像组学模型、影像组学特征、深度学习影像组学特征及DLRN,采用AUC、准确率、校准曲线和决策曲线分析评价模型效用。

诊断标准与关键数值

  • DLRN鉴别高分化脂肪肉瘤与腹膜后脂肪瘤的训练组AUC 0.981、准确率0.933,外部验证组AUC 0.861、准确率0.810;DeLong检验显示DLRN优于临床-影像组学模型和影像组学特征模型(训练组AUC 0.981 vs 0.890 vs 0.751,验证组AUC 0.861 vs 0.724 vs 0.700,均P<0.05);DLRN与深度学习影像组学特征模型性能无显著差异(训练组AUC 0.981 vs 0.969,验证组AUC 0.861 vs 0.837,均P>0.05);校准曲线和决策曲线分析显示列线图具有良好的校准和实质性的临床优势。

临床应用与阅片要点

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

RATIONALE AND OBJECTIVES: To assess the efficacy of a preoperative contrast-enhanced CT (CECT)-based deep learning radiomics nomogram (DLRN) for predicting murine double minute 2 (MDM2) gene amplification as a means of distinguishing between retroperitoneal well-differentiated liposarcomas (WDLPS) and lipomas.

METHODS: This retrospective multi-center study included 167 patients (training/external test cohort, 104/63) with MDM2-positive WDLPS or MDM2-negative lipomas. Clinical data and CECT features were independently measured and analyzed by two radiologists. A clinico-radiological model, radiomics signature (RS), deep learning and radiomics signature (DLRS), and a DLRN incorporating radiomics and deep learning features were developed to differentiate between WDLPS and lipoma. The model utility was evaluated based on the area under the receiver operating characteristic curve (AUC), accuracy, calibration curve, and decision curve analysis (DCA).

RESULTS: The DLRN showed good performance for distinguishing retroperitoneal lipomas and WDLPS in the training (AUC, 0.981; accuracy, 0.933) and external validation group (AUC, 0.861; accuracy, 0.810). The DeLong test revealed the DLRN was noticeably better than clinico-radiological and RS models (training: 0.981 vs. 0.890 vs. 0.751; validation: 0.861 vs. 0.724 vs. 0.700; both P < 0.05); however, no discernible difference in performance was seen between the DLRN and DLRS (training: 0.981 vs. 0.969; validation: 0.861 vs. 0.837; both P > 0.05). The calibration curve analysis and DCA demonstrated that the nomogram exhibited good calibration and offered substantial clinical advantages.

CONCLUSION: The DLRN exhibited strong predictive capability in predicting WDLPS and retroperitoneal lipomas preoperatively, making it a promising imaging biomarker that can facilitate personalized management and precision medicine.

来源:Acad Radiol,查看原文。版权归原作者所有。

引用

  1. Xu J, Miao L, Wang CX, et al. Preoperative Contrast-Enhanced CT-Based Deep Learning Radiomics Model for Distinguishing Retroperitoneal Lipomas and Well‑Differentiated Liposarcomas. Acad Radiol. 2024. PMID: 39003228. doi:10.1016/j.acra.2024.06.035

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。